Cargando…
Prevalence of human parvovirus B19 in Chinese plasma pools for manufacturing plasma derivatives
BACKGROUND: Human parvovirus B19 (B19V) is a frequent contaminant of blood and plasma-derived medicinal products. To ensure the quality and safety of plasma-derived products, European regulations, Plasma Protein Therapeutics Association (PPTA) standard and FDA guidelines require testing of manufactu...
Autores principales: | Jia, Junting, Ma, Yuyuan, Zhao, Xiong, Guo, Yi, Huangfu, Chaoji, Fang, Chi, Fan, Rui, Lv, Maomin, Yin, Huiqiong, Zhang, Jingang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4596515/ https://www.ncbi.nlm.nih.gov/pubmed/26445095 http://dx.doi.org/10.1186/s12985-015-0396-z |
Ejemplares similares
-
Existence of various human parvovirus B19 genotypes in Chinese plasma pools: genotype 1, genotype 3, putative intergenotypic recombinant variants and new genotypes
por: Jia, Junting, et al.
Publicado: (2016) -
Identification of human parvovirus 4 genotypes 1 and 2 in Chinese source plasma pools
por: Jia, Junting, et al.
Publicado: (2021) -
Construction and characterization of an infectious replication competent clone of porcine endogenous retrovirus from Chinese miniature pigs
por: Xiang, Silong, et al.
Publicado: (2013) -
3,3′-Diindolylmethane: A Promising Sensitizer of γ-Irradiation
por: Wang, Wenjing, et al.
Publicado: (2015) -
Parvovirus B19 DNA and antibodies in Chinese plasma donors, plasma pools and plasma derivatives
por: Sun, Pan, et al.
Publicado: (2023)